南京思锘新药研发有限公司注册在江北新区的创新放射性药物研发公司,专注于通过利用靶向放射性同位素的力量来改善癌症患者的治疗效果。思锘新药具有诊断和治疗的独特优势。通过替换放射性同位素,相同的药物偶联物可用于诊断成像和治疗用途。通过成像直接可视化肿瘤对药物偶联物的吸收,允许正确选择患者以接受治疗性放射性同位素。同时依托于独具特色的Cytostar®单细胞高特异性高亲和力抗体筛选平台和高通量靶向多肽筛选平台,结合创始合伙人团队二十余年核药开发评价经验以及深厚的核医药行业和产业资源,思锘新药旨在建立具有核心药研技术和先进开发策略的创新放射性药物研发平台,降低失败风险,加快产品上市,为诊疗一体化精准医疗和人类健康做贡献。
What does 南京思锘新药研发有限公司 require? Who is 南京思锘新药研发有限公司 hiring? recruitment: 生物/制药/化工/环保类占比最多占38.5%,其次是销售类占30.8%. What education can get in at ? 本科占比最多占61.5%,其次是大专占23.1%. High education required at ? 硕士占15.4%. Work experience required at ? 不限占比最多占46.2%,其次是5-10年占30.8%. Where are the job locations at ? 南京占比最多占84.6%,其次是泸州占15.4%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows